terfenadine has been researched along with Actinic Reticuloid Syndrome in 5 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of terfenadine on the response to irradiation with blue light was measured in seven patients with erythropoietic protoporphyria." | 7.68 | Inhibition of photosensitivity in erythropoietic protoporphyria with terfenadine. ( Diffey, BL; Farr, PM; Matthews, JN, 1990) |
| "Solar urticaria is a rare photodermatosis, but it is extremely incapacitating and therapy is usually ineffective." | 5.28 | [Treatment of solar urticaria: advantage of terfenadine]. ( Civatte, J; Jeanmougin, M; Manciet, JR; Moulin, JP, 1989) |
| "The effect of terfenadine on the response to irradiation with blue light was measured in seven patients with erythropoietic protoporphyria." | 3.68 | Inhibition of photosensitivity in erythropoietic protoporphyria with terfenadine. ( Diffey, BL; Farr, PM; Matthews, JN, 1990) |
| " In cases of failure, treatment was switched to omalizumab at doses of < 300 mg/month with incremental dosage increases as necessary (monthly dose range, 150-600 mg/month)." | 1.51 | Real-life experience in the treatment of solar urticaria: retrospective cohort study. ( Enk, CD; Hodak, E; Lapidoth, M; Levi, A; Mazor, S; Snast, I; Uvaidov, V, 2019) |
| "The treatment with terfenadine was continued." | 1.35 | Solar urticaria successfully treated with intravenous immunoglobulins. ( Dubertret, L; Frémont, G; Jeanmougin, M; Maksimovic, L; Viguier, M, 2009) |
| "Solar urticaria is a rare photodermatosis, but it is extremely incapacitating and therapy is usually ineffective." | 1.28 | [Treatment of solar urticaria: advantage of terfenadine]. ( Civatte, J; Jeanmougin, M; Manciet, JR; Moulin, JP, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Snast, I | 1 |
| Lapidoth, M | 1 |
| Uvaidov, V | 1 |
| Enk, CD | 2 |
| Mazor, S | 1 |
| Hodak, E | 1 |
| Levi, A | 2 |
| Maksimovic, L | 1 |
| Frémont, G | 1 |
| Jeanmougin, M | 2 |
| Dubertret, L | 1 |
| Viguier, M | 1 |
| Farr, PM | 1 |
| Diffey, BL | 1 |
| Matthews, JN | 1 |
| Manciet, JR | 1 |
| Moulin, JP | 1 |
| Civatte, J | 1 |
5 other studies available for terfenadine and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Real-life experience in the treatment of solar urticaria: retrospective cohort study.
Topics: Acetates; Adolescent; Adult; Aged; Anti-Allergic Agents; Cetirizine; Child; Cohort Studies; Cyclopro | 2019 |
Treatment of solar urticaria using antihistamine and leukotriene receptor antagonist combinations tailored to disease severity.
Topics: Acetates; Adolescent; Adult; Cetirizine; Child; Child, Preschool; Cyclopropanes; Drug Therapy, Combi | 2015 |
Solar urticaria successfully treated with intravenous immunoglobulins.
Topics: Adult; Histamine H1 Antagonists, Non-Sedating; Humans; Immunoglobulins, Intravenous; Immunologic Fac | 2009 |
Inhibition of photosensitivity in erythropoietic protoporphyria with terfenadine.
Topics: Adolescent; Adult; Benzhydryl Compounds; beta Carotene; Carotenoids; Child; Drug Therapy, Combinatio | 1990 |
[Treatment of solar urticaria: advantage of terfenadine].
Topics: Adult; Benzhydryl Compounds; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Photosensi | 1989 |